Company / Working Capital per Share
Krystal Biotech, Inc. Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$32.01
FY2025
5-year range
$13.92 / $32.01
FY2021-FY2025
Trend
+41.2%
vs FY2024
Sector context
#11 of 210
Health Care
What the data says
Among 210 Health Care companies, Krystal Biotech, Inc. is in the top 5% for working capital per share. Working Capital per Share has increased for 3 consecutive years, from $13.92 in FY2022 to $32.01 in FY2025.
Based on SEC 10-K filings.
32.01 in FY2025 with a 5-year CAGR of +18.3%. Top quartile in the Health Care sector.
Improved from $21.53 to $32.01 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +32.0%
- 5-Year CAGR
- +18.3%
- 10-Year CAGR
- -
Sector benchmark
-78.2% below sector average
Key checks
Key Insights
- Krystal Biotech, Inc.'s working capital per share has grown for 3 consecutive years.
- In FY2025, working capital per share increased 41.2% year-over-year.
- Ranks #11 out of 210 companies in the Health Care sector.
- Lowest working capital per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 5.66 (safe zone, above 2.9 threshold)
- Strong profit margin: 30.7%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $32.01 | +41.2% |
| FY2024 | $22.67 | +5.3% |
| FY2023 | $21.53 | +54.7% |
| FY2022 | $13.92 | -25.8% |
| FY2021 | $18.77 | +35.8% |
| FY2020 | $13.82 | +14.1% |
| FY2019 | $12.11 | +23.3% |
| FY2018 | $9.82 | +6.9% |
| FY2017 | $9.19 | +279.4% |
| FY2016 | $2.42 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026